Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method (Q84241826)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

1 reference

1 reference

1 reference

D Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

S Kapre

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

A Goel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

K Suresh

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

S Beri

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

J Hickling

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

J Jensen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M Lal

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

J M Preaud

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

M Laforce

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

D Kristensen

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

15 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

5093-5099

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

Frequency and causes of vaccine wastage

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Exposure to heat and freezing in the vaccine cold chain in Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Freezing temperatures in the vaccine cold chain: a systematic literature review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Vacuum foam drying for preservation of LaSota virus: effect of additives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Drying a tuberculosis vaccine without freezing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Stabilizing formulations for inhalable powders of live-attenuated measles virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Inhaled insulin's last gasp?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Aerosolization properties, surface composition and physical state of spray-dried protein powders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Why is trehalose an exceptional protein stabilizer? An analysis of the thermal stability of proteins in the presence of the compatible osmolyte trehalose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Fast dynamics and stabilization of proteins: binary glasses of trehalose and glycerol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

The trehalose myth revisited: introduction to a symposium on stabilization of cells in the dry state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Characterization of the freeze sensitivity of a hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

A heat-stable hepatitis B vaccine formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Opportunities and challenges of developing thermostable vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Characterization of a thermostable hepatitis B vaccine formulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Spray drying of an attenuated live Newcastle disease vaccine virus intended for respiratory mass vaccination of poultry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Improving birth dose coverage of hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.04.112

10.1016/J.VACCINE.2010.04.112

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20478345%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference